Composition:
Each ml contains: | Buparvaquone 50mg | Furosemide BP 55mg | Sorbitan mono oleate BP 100mg (as preservative) Oil base
Indications:
For the treatment of theileriosis (east coast fever) particularly for advanced cases with pulmonary oedema Buparvaquone kills theilerial schizonts (in lymphoid cells) and piroplasms (in red blood cells) and it supresses preschizont stages during the incubation period of disease Buparvaquone kill the parasite through its actions on their mitochondrial electron transport (respiratory) system. Furosemide is a diuretic, which resolves pulmonary oedema.
Dosage & Administration:
Injection by the Intramuscular route into the neck muscles at the rate of 1ml / 20 kg (2.5 mg per kg of buparvaquone and 2.75 mg/kg of furosemide) Repeat afer 48 hours. | In cases of exceptionally severe infections with pulmonary oedema, further treatment at half the dosage rate may be required at 24 hour interval.
Warning:
/ Precaution: | Localised swelling may occur at Injection sites but it resolves in a few days. | KenVaq Plus is very safe so overdosage is unlikely to cause significant adverse effect. KenVaq Plus must be administered only by the Intramuscular route. Intravenous Injection may cause severe shock | KenVaq Plus is poorly mobilised afer subcutaneous injection and its curative effect is greatly reduced. | Furosemide is chemically similar to the sulphonamides so KenVaq Plus should not be used in animal with sulphonamide sensitivity
Withdrawal Period:
Milk for human consumption should not be taken from animals treated with KenVaq Plus until atleast 48 hours afer treatment. | Milk for animals treated with KenVaq Plus is safe for consumption by calves. Animals should not be slaughtered for human consumption until at least 42 days afer treatment with KenVaq Plus.
Storage:
Store in a dry place, below 30°C, protected from direct sunlight. | Keep all medicines out of reach of children.
Presentation:
50ml & 100ml | FOR VETERINARY USE ONLY
